Amundi Elanco Animal Health Inc Transaction History

Amundi

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$8.08 - $10.37 $109 Million - $140 Million	-13,473,812 Reduced 84.25%	2,519,102 $25.3 Million
Q1 2023 May 15, 2023	SELL	$8.79 - $14.58 $37.2 Million - $61.7 Million	-4,233,910 Reduced 20.93%	15,992,914 $150 Million
Q4 2022 Feb 14, 2023	SELL	$11.49 - $13.65 $22.6 Million - $26.8 Million	-1,962,877 Reduced 8.85%	20,226,824 $247 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $82.1 Million - $215 Million	6,618,586 Added 42.51%	22,189,701 $283 Million
Q2 2022 Aug 15, 2022	BUY	$19.63 - $26.62 $25.8 Million - $35 Million	1,313,013 Added 9.21%	15,571,115 $305 Million
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $13.6 Million - $16 Million	-550,059 Reduced 3.71%	14,258,102 $379 Million
Q4 2021 Feb 14, 2022	BUY	$27.74 - $34.09 $14.3 Million - $17.6 Million	516,184 Added 3.61%	14,808,161 $401 Million
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $58 Million - $72.9 Million	1,985,388 Added 16.13%	14,291,977 $456 Million
Q2 2021 Aug 16, 2021	BUY	$28.76 - $35.98 $354 Million - $443 Million	12,306,589 New	12,306,589 $427 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.